Distinct myeloid antigen-presenting cells dictate differential fates of tumor-specific CD8+ T cells in pancreatic cancer
We investigate how myeloid subsets differentially shape immunity to pancreatic ductal adenocarcinoma (PDA). We show that tumor antigenicity sculpts myeloid cell composition and functionality. Antigenicity promotes accumulation of type 1 dendritic cells (cDC1), which is driven by Xcr1 signaling, and...
Auteurs principaux: | Adam L. Burrack, Zoe C. Schmiechen, Michael T. Patterson, Ebony A. Miller, Ellen J. Spartz, Meagan R. Rollins, Jackson F. Raynor, Jason S. Mitchell, Tsuneyasu Kaisho, Brian T. Fife, Ingunn M. Stromnes |
---|---|
Format: | Article |
Langue: | English |
Publié: |
American Society for Clinical investigation
2022-04-01
|
Collection: | JCI Insight |
Sujets: | |
Accès en ligne: | https://doi.org/10.1172/jci.insight.151593 |
Documents similaires
-
Tumor-specific CD4 T cells instruct monocyte fate in pancreatic ductal adenocarcinoma
par: Michael T. Patterson, et autres
Publié: (2023-07-01) -
Mechanisms Governing Immunotherapy Resistance in Pancreatic Ductal Adenocarcinoma
par: Zoe C. Schmiechen, et autres
Publié: (2021-01-01) -
Germline T cell receptor exchange results in physiological T cell development and function
par: Meagan R. Rollins, et autres
Publié: (2023-02-01) -
Combination PD-1 and PD-L1 Blockade Promotes Durable Neoantigen-Specific T Cell-Mediated Immunity in Pancreatic Ductal Adenocarcinoma
par: Adam L. Burrack, et autres
Publié: (2019-08-01) -
XCR1+ DCs are critical for T cell-mediated immunotherapy of chronic viral infections
par: Eva Domenjo-Vila, et autres
Publié: (2023-02-01)